Published by Josh White on 19th October 2020
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics updated the market on its opposition proceedings with Teva Pharmaceutical Industries on Monday, confirming that Teva had withdrawn its appeal and opposition over two of Shield's patents.
URL: http://www.digitallook.com/dl/news/story/31318470/...